Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-12-066454
Filing Date
2012-12-21
Accepted
2012-12-21 08:01:10
Documents
2
Period of Report
2012-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd362993.html 3  
1 FORM 3 rrd362993.xml 3 2777
2 POWER OF ATTORNEY rrd325786_368305.htm EX-24. 5013
  Complete submission text file 0001181431-12-066454.txt   9234
Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1 353 1 709 4700
Prothena Corp plc (Issuer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROTHENA CORPORATION PLC 650 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Schenk Dale B. (Reporting) CIK: 0001564371 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35676 | Film No.: 121279107